At Last: Eli Lilly Publishes Data for Catastrophic Alzheimer's Trial Post author:Sam Post published:January 24, 2018 Post category:BioPharma Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace You Might Also Like Genentech Dumps Another $650M in New Haven Biotech Arvinas November 14, 2017 Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017 Don't Count Us Out: Pfizer Hints at a Possible Bristol-Myers Squibb Deal May 2, 2017
Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017
